1 Trademark Results found for "IGNYESSO*"

Also try searching for:

IGNY*

*SSO

IG*SO

Mark	Details	Status	Class/Description
	IGNYESSO GLAXO GROUP LIMITED 2189387 14 Apr 2022	REGISTERED on 12 Jan 2024	Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders, namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment, namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin and skin structure infections, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders, namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction, namely erectile dysfunction, male and female sexual dysfunction disorders, namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders, namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue, namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy.

REGISTERED

on 12 Jan 2024

IGNYESSO

GLAXO GROUP LIMITED

2189387 · 14 Apr 2022

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders, namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment, namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin and skin structure infections, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders, namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction, namely erectile dysfunction, male and female sexual dysfunction disorders, namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders, namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue, namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy.

Pharmaceutical preparations for use as anti-infectives; pharmaceutical...

Owners

Glaxo group limited (1)

Categories

Class 5 (1)

Correspondents

Borden ladner gervais llp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

€528/ 1 class + gov fee

United States

€88/ 1 class + gov fee

Canada

€528/ 1 class + gov fee

Mexico

€440/ 1 class + gov fee

European Union

€617/ 1 class + gov fee

China

€440/ 1 class + gov fee

South Korea

€616/ 1 class + gov fee

Japan

€704/ 1 class + gov fee

India

€88/ 1 class + gov fee

United Kingdom

€440/ 1 class + gov fee

Australia

€264/ 1 class + gov fee

Israel

€616/ 1 class + gov fee

United Arab Emirates

€616/ 1 class + gov fee

New Zealand

€616/ 1 class + gov fee

Brazil

€440/ 1 class + gov fee

Taiwan

€704/ 1 class + gov fee

Ukraine

€704/ 1 class + gov fee

Indonesia

€616/ 1 class + gov fee

South Africa

€440/ 1 class + gov fee

Singapore

€704/ 1 class + gov fee

Saudi Arabia

€704/ 1 class + gov fee

Afghanistan

€704/ 1 class + gov fee

Algeria

€704/ 1 class + gov fee

Argentina

€352/ 1 class + gov fee

Austria

€792/ 1 class + gov fee

Bahrain

€616/ 1 class + gov fee

Bangladesh

€528/ 1 class + gov fee

Benelux

€880/ 1 class + gov fee

Bhutan

€792/ 1 class + gov fee

Bolivia

€704/ 1 class + gov fee

Botswana

€1,144/ 1 class + gov fee

British Virgin Islands

€1,056/ 1 class + gov fee

Bulgaria

€704/ 1 class + gov fee

Cambodia

€704/ 1 class + gov fee

Chile

€440/ 1 class + gov fee

Colombia

€616/ 1 class + gov fee

Congo

€1,056/ 1 class + gov fee

Costa Rica

€792/ 1 class + gov fee

Croatia

€792/ 1 class + gov fee

Cyprus

€880/ 1 class + gov fee

Czech Republic

€792/ 1 class + gov fee

Denmark

€704/ 1 class + gov fee

Greenland

€704/ 1 class + gov fee

Aruba

€1,056/ 1 class + gov fee

Macau

€616/ 1 class + gov fee

Curacao

€1,056/ 1 class + gov fee

Dominican Republic

€792/ 1 class + gov fee

Ecuador

€704/ 1 class + gov fee

Egypt

€616/ 1 class + gov fee

El Salvador

€704/ 1 class + gov fee

Ethiopia

€968/ 1 class + gov fee

France

€792/ 1 class + gov fee

Gaza

€704/ 1 class + gov fee

Germany

€792/ 1 class + gov fee

Greece

€704/ 1 class + gov fee

Guatemala

€792/ 1 class + gov fee

Haiti

€792/ 1 class + gov fee

Honduras

€792/ 1 class + gov fee

Hong Kong (SAR)

€792/ 1 class + gov fee

Hungary

€968/ 1 class + gov fee

Iraq

€1,320/ 1 class + gov fee

Italy

€792/ 1 class + gov fee

Jordan

€704/ 1 class + gov fee

Kazakhstan

€704/ 1 class + gov fee

Kenya

€792/ 1 class + gov fee

Kuwait

€704/ 1 class + gov fee

Laos

€616/ 1 class + gov fee

Lebanon

€880/ 1 class + gov fee

Lesotho

€1,056/ 1 class + gov fee

Libya

€792/ 1 class + gov fee

Madrid Protocol (WIPO)

€1,760/ 1 class + gov fee

Malawi

€968/ 1 class + gov fee

Malaysia

€616/ 1 class + gov fee

Maldives

€880/ 1 class + gov fee

Morocco

€880/ 1 class + gov fee

Mozambique

€792/ 1 class + gov fee

Myanmar

€704/ 1 class + gov fee

Namibia

€704/ 1 class + gov fee

Nepal

€616/ 1 class + gov fee

Nicaragua

€792/ 1 class + gov fee

Norway

€792/ 1 class + gov fee

Oman

€968/ 1 class + gov fee

Pakistan

€704/ 1 class + gov fee

Panama

€792/ 1 class + gov fee

Paraguay

€792/ 1 class + gov fee

Peru

€704/ 1 class + gov fee

Philippines

€792/ 1 class + gov fee

Poland

€440/ 1 class + gov fee

Portugal

€792/ 1 class + gov fee

Puerto Rico

€792/ 1 class + gov fee

Qatar

€704/ 1 class + gov fee

Romania

€792/ 1 class + gov fee

Serbia

€792/ 1 class + gov fee

Slovakia

€792/ 1 class + gov fee

Spain

€792/ 1 class + gov fee

Sri Lanka

€616/ 1 class + gov fee

Swaziland

€1,144/ 1 class + gov fee

Sweden

€704/ 1 class + gov fee

Switzerland

€792/ 1 class + gov fee

Thailand

€704/ 1 class + gov fee

Tunisia

€792/ 1 class + gov fee

Turkey

€704/ 1 class + gov fee

Uganda

€616/ 1 class + gov fee

United Republic of Tanzania

€616/ 1 class + gov fee

Uruguay

€704/ 1 class + gov fee

Venezuela

€792/ 1 class + gov fee

Vietnam

€704/ 1 class + gov fee

West Bank, Palestine

€704/ 1 class + gov fee

Yemen

€1,496/ 1 class + gov fee

Albania

€792/ 1 class + gov fee

Andorra

€792/ 1 class + gov fee

Angola

€1,144/ 1 class + gov fee

Antigua and Barbuda

€1,056/ 1 class + gov fee

Armenia

€704/ 1 class + gov fee

Azerbaijan

€704/ 1 class + gov fee

Bahamas

€1,232/ 1 class + gov fee

Barbados

€1,144/ 1 class + gov fee

Belgium

€880/ 1 class + gov fee

Belize

€1,144/ 1 class + gov fee

Benin

€704/ 1 class + gov fee

Bosnia and Herzegovina

€880/ 1 class + gov fee

Brunei

€1,144/ 1 class + gov fee

Burkina Faso

€704/ 1 class + gov fee

Burundi

€1,056/ 1 class + gov fee

Cabo Verde

€792/ 1 class + gov fee

Cameroon

€704/ 1 class + gov fee

Central African Republic (CAR)

€704/ 1 class + gov fee

Chad

€704/ 1 class + gov fee

Comoros

€704/ 1 class + gov fee

Cote d'Ivoire

€704/ 1 class + gov fee

Czechia

€880/ 1 class + gov fee

Djibouti

€1,056/ 1 class + gov fee

Dominica

€1,144/ 1 class + gov fee

Equatorial Guinea

€704/ 1 class + gov fee

Eritrea

€880/ 1 class + gov fee

Estonia

€1,144/ 1 class + gov fee

Eswatini

€1,144/ 1 class + gov fee

Fiji

€792/ 1 class + gov fee

Finland

€616/ 1 class + gov fee

Gabon

€704/ 1 class + gov fee

Gambia

€792/ 1 class + gov fee

Georgia

€704/ 1 class + gov fee

Ghana

€880/ 1 class + gov fee

Grenada

€1,144/ 1 class + gov fee

Guinea

€704/ 1 class + gov fee

Guinea-Bissau

€704/ 1 class + gov fee

Guyana

€1,144/ 1 class + gov fee

Iceland

€1,144/ 1 class + gov fee

Ireland

€704/ 1 class + gov fee

Jamaica

€1,056/ 1 class + gov fee

Kiribati

€880/ 1 class + gov fee

Kosovo

€792/ 1 class + gov fee

Kyrgyzstan

€792/ 1 class + gov fee

Latvia

€616/ 1 class + gov fee

Liberia

€880/ 1 class + gov fee

Liechtenstein

€880/ 1 class + gov fee

Lithuania

€616/ 1 class + gov fee

Luxembourg

€880/ 1 class + gov fee

Madagascar

€880/ 1 class + gov fee

Mali

€704/ 1 class + gov fee

Malta

€528/ 1 class + gov fee

Marshall Islands

€880/ 1 class + gov fee

Mauritania

€704/ 1 class + gov fee

Mauritius

€880/ 1 class + gov fee

Micronesia

€880/ 1 class + gov fee

Moldova

€880/ 1 class + gov fee

Monaco

€1,232/ 1 class + gov fee

Mongolia

€528/ 1 class + gov fee

Montenegro

€792/ 1 class + gov fee

Nauru

€880/ 1 class + gov fee

Netherlands

€880/ 1 class + gov fee

Niger

€704/ 1 class + gov fee

Nigeria

€352/ 1 class + gov fee

North Macedonia

€792/ 1 class + gov fee

Palau

€880/ 1 class + gov fee

Palestine

€880/ 1 class + gov fee

Papua New Guinea

€704/ 1 class + gov fee

Rwanda

€880/ 1 class + gov fee

Saint Kitts and Nevis

€1,144/ 1 class + gov fee

Saint Lucia

€1,144/ 1 class + gov fee

Saint Vincent and the Grenadines

€1,144/ 1 class + gov fee

Samoa

€1,056/ 1 class + gov fee

San Marino

€880/ 1 class + gov fee

Sao Tome and Principe

€880/ 1 class + gov fee

Senegal

€704/ 1 class + gov fee

Seychelles

€880/ 1 class + gov fee

Sierra Leone

€880/ 1 class + gov fee

Slovenia

€792/ 1 class + gov fee

Solomon Islands

€880/ 1 class + gov fee

Somalia

€880/ 1 class + gov fee

South Sudan

€880/ 1 class + gov fee

Suriname

€1,408/ 1 class + gov fee

Tajikistan

€704/ 1 class + gov fee

Tanzania

€616/ 1 class + gov fee

Timor-Leste

€880/ 1 class + gov fee

Togo

€704/ 1 class + gov fee

Tonga

€1,144/ 1 class + gov fee

Trinidad and Tobago

€1,056/ 1 class + gov fee

Turkmenistan

€704/ 1 class + gov fee

Tuvalu

€880/ 1 class + gov fee

Uzbekistan

€616/ 1 class + gov fee

Vanuatu

€1,056/ 1 class + gov fee

Zambia

€792/ 1 class + gov fee

Zimbabwe

€792/ 1 class + gov fee

OAPI

€792/ 1 class + gov fee

ARIPO

€880/ 1 class + gov fee

End of search results

Page 1 of 1